BENJAMIN J. ZESKIND - 28 Feb 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role: PRESIDENT AND CEO, Director, 10%+ Owner
Signature: /s/ Michael D. Bookman, Attorney-in-Fact for Benjamin J. Zeskind
Issuer symbol: IMRX
Transactions as of: 28 Feb 2022
Net transactions value: +$6,020
Form type: 4
Filing time: 01 Mar 2022, 16:19:54 UTC
Previous filing: 14 Feb 2022
Next filing: 24 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMRX	Class A Common Stock	Options Exercise	$6,020	+2,000	+0.09%	$3.01	2,254,352	28 Feb 2022	Direct
holding	IMRX	Class A Common Stock						894,927	28 Feb 2022	See Foonote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMRX	Stock Option	Options Exercise	$0	-2,000	-0.95%	$0.000000	208,000	28 Feb 2022	Class A Common Stock	2,000	$3.01	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.
F2	The option has fully vested and is currently exercisable.